The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy

Background: There might be differential sensitivity to neoadjuvant chemotherapy (NAC) in patients with primary muscle-invasive bladder cancer (MIBC) in comparison to patients with secondary MIBC after a history of non–muscle-invasive disease. Objective: To investigate pathologic response rates and s...

Full description

Bibliographic Details
Main Authors: David D'Andrea, Shahrokh F. Shariat, Francesco Soria, Andrea Mari, Laura S. Mertens, Ettore Di Trapani, Diego M. Carrion, Benjamin Pradere, Renate Pichler, Ronan Filippot, Guillaume Grisay, Francesco Del Giudice, Ekaterina Laukhtina, David Paulnsteiner, Wojciech Krajewski, Sonia Vallet, Martina Maggi, Ettore De Berardinis, Mario Álvarez-Maestro, Stephan Brönimann, Fabrizio Di Maida, Bas W.G. van Rhijn, Kees Hendricksen, Marco Moschini
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:European Urology Open Science
Subjects:
Neoadjuvant chemotherapy
Bladder cancer
Response
Survival
Primary
Secondary
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168322006073

Internet

http://www.sciencedirect.com/science/article/pii/S2666168322006073

Similar Items